当前位置： SCI文献检索 > JOURNAL OF PSYCHOSOMATIC RESEARCH期刊下所有文献 > A Pilot Mind-Body Resiliency Intervention Targeting Fear of Recurrence among Cancer Survivors.

A Pilot Mind-Body Resiliency Intervention Targeting Fear of Recurrence among Cancer Survivors.

Abstract：

OBJECTIVE:Interventions for fear of recurrence (FOR) of cancer have nominal effects, perhaps due to limited integration of empirically supported skills. This pilot trial tested the acceptability and feasibility of a multimodal, mind-body resiliency intervention targeting FOR among survivors of various cancers. METHODS:Early stage cancer survivors 3-30 months post-treatment were recruited to participate in an eight-session in-person mind-body resiliency group intervention that taught relaxation skills, cognitive-behavioral techniques, healthy lifestyle behaviors, mindfulness meditation, and positive psychology skills all targeted for FOR. Primary outcomes were feasibility (enrollment rate, session attendance, survey completion, skills practice) and acceptability (enjoyableness, convenience, helpfulness, relevance). Patient-reported outcomes (FOR, uncertainty intolerance, cancer-related uncertainty, perceived stress, resiliency, positive affect, and coping skills) were collected at baseline, post-intervention, +1 month, and +3 months. Exit interviews assessed survivors' reported benefits. RESULTS:Participants (N = 4 groups, 23 survivors, enrollment response rate = 58%) included survivors of seven common cancer types who were on average 12 months post-treatment. Attendance was high (M = 6.1 sessions), and 96% of survivors completed all surveys. Sustained increases in relaxation skills practice 3+ days/week were reported (baseline = 16%, post-intervention = 76%, +3 months = 71%). Most sessions (87%) were rated as highly or very highly acceptable. Moderate-to-large (d = 0.87) improvements in FOR severity were observed post-intervention (p < .01) and across assessments (p < .01), with similar changes observed in other patient-reported outcomes. Exit interviews revealed behavioral, cognitive, emotional, and existential benefits. CONCLUSIONS:The targeted mind-body resiliency intervention shows promising acceptability, feasibility, and favorable changes in FOR and coping skills practice. Further adaptation and testing in a randomized trial are warranted. ClinicalTrials.govRegistration Number: NCT03695406.

journal_name

J Psychosom Res

journal_title

Journal of psychosomatic research

authors

Hall DL,Park ER,Cheung T,Davis RB,Yeh GY

doi

10.1016/j.jpsychores.2020.110215

subject

Has Abstract

pub_date

2020-08-10 00:00:00

pages

110215

eissn

0022-3999

issn

1879-1360

pii

S0022-3999(20)30777-7

journal_volume

137

pub_type

杂志文章

在线工具

A Pilot Mind-Body Resiliency Intervention Targeting Fear of Recurrence among Cancer Survivors.